Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

Medicines Adaptive Pathways to Patients (MAPPs) seeks to foster access to novel beneficial treatments for the right patient groups at the earliest appropriate time in the product life‐span, in a sustainable fashion. We summarize the MAPPs engagement process and critical questions to be asked at each...

詳細記述

保存先:
書誌詳細
出版年:Clin Pharmacol Ther
主要な著者: Eichler, Hans‐Georg, Bedlington, Nicola, Boudes, Mathieu, Bouvy, Jacoline C., Broekmans, André W., Cerreta, Francesca, Faulkner, Stuart D., Forda, Susan R., Joos, Angelika, Le Cam, Yann, Mayer, Mark H., Pirard, Vinciane, Corriol‐Rohou, Solange
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
Reviews
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6585618/
https://ncbi.nlm.nih.gov/pubmed/29901216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1121
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料